Showing results (251-260 of 275) with videos related to
Sort By:
Pageof 28
Clinics in Liver Disease|July 4, 2019
Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Transplant RecipientsJoe Sasadeusz, Andrew Grigg, Peter D Hughes, et al.Journal of Viral Hepatitis|May 9, 2020
HBV variants are common in the 'immune-tolerant' phase of chronic hepatitis BLilly Yuen, Peter A Revill, Gillian Rosenberg, et al.The Lancet. Gastroenterology & Hepatology|July 15, 2021
Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseasesMohammed Eslam, Aijaz Ahmed, Jean-Pierre Després, et al.Cancer Chemotherapy and Pharmacology|July 21, 2014
Inhibition of Hec1 as a novel approach for treatment of primary liver cancerLynn Y L Huang, Chia-chi Chang, Ying-Shuan Lee, et al.Journal of Virology|January 25, 2008
Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virusJoseph J Y Sung, Stephen K W Tsui, Chi-Hang Tse, et al.Hepatology (Baltimore, Md.)|June 24, 2008
Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistanceScott Preiss, Margaret Littlejohn, Peter Angus, et al.The Lancet. Gastroenterology & Hepatology|April 14, 2017
Management of hepatitis C virus infection in the Asia-Pacific region: an updateSeng Gee Lim, Alessio Aghemo, Pei-Jer Chen, et al.Science Translational Medicine|September 29, 2017
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAgChristine I Wooddell, Man-Fung Yuen, Henry Lik-Yuen Chan, et al.Scientific Reports|November 25, 2015
Composition and Interactions of Hepatitis B Virus Quasispecies Defined the Virological Response During Telbivudine TherapyBin Zhou, Hui Dong, Yungang He, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 8, 2017
Identification of hepatitis C virus 2k/1b intergenotypic recombinants in GeorgiaMamuka Zakalashvili, Jaba Zarkua, Michael Weizenegger, et al.Pageof 28